Nanobiotix
2 known investors
Nanobiotix is a biotechnology company developing NBTXR3, a physics-based radioenhancer designed to increase radiotherapy effectiveness in solid tumors including head, neck, and lung cancers. The company partners with Johnson & Johnson's Janssen Pharmaceutica for co-development and commercialization.